Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06995807

EL-SHIN Therapy for Depressive Symptoms

This is a research aiming to find the effectiveness of an innovative therapy, EL-SHIN THERAPY, in ameliorating depressive symptoms.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Depressive Disorder Mental Disorders Mood Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Monash University Malaysia

Kuala Lumpur, Malaysia

Location status: Recruiting

Location contact

Ai Shin LIM, PhD

CONTACT

About this study

This study evaluates the effectiveness of EL-SHIN® Therapy, a novel adjunctive intervention in alleviating depressive symptoms.

There are three components in this therapy:

  • Lavender Therapy
  • GRATEFULNESS® Therapy
  • Fasting with exercise and light therapy

The study includes two phases: a quantitative clinical trial and a qualitative focus group.

Assessments will use DASS-21, MHQoL, and SQS scales with the intervention delivered in English over 3-4 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: Above 18 yrs old
  • DASS-21 scores:

"Moderately Depressed (Score: 14-20)", "Moderately Anxious (Score: 10-14)" & "Moderately Stressed (Score: 19-25)"

  • Non-Muslim (Due to legal restriction in Malaysia for this religion)
  • English literate
  • Believers in Creationism

Exclusion criteria

  • Muslim (legal restrictions in Malaysia for this religion).
  • Non-English literate (research will be conducted in English only).
  • Individuals with any other medical conditions or on current medication To reduce potential complications or confounding factors).

Treatment and study plan

EL-SHIN THERAPY

Other

Participants will be randomly assigned to Group A and Group B. Group A : Attend a talk on Malaysia Tourism + current coping strategies.

Group B : EL-SHIN® Therapy + current coping strategies. Duration of therapies: 2 weeks Assessments using (i) DASS-21 (ii) MHQoL (iii) SLEEP QUALITY SCALE (SQS) at baseline, after 1st week & 2nd weeks for both groups. Assessment will be done on end of 3rd week to see effect when EL-SHIN Therapy Stopped.

Group B participants: Attend a workshop on administration of EL-SHIN® Therapy. Will reinitiate EL-SHIN Therapy on the 4th week and assess on the 8th day to see the effect.

Primary outcomes

  1. DASS-21 Scale

    Time frame: 3 to 4 weeks

    Measuring severity of Depression, Anxiety and Stress Level. Higher score indicating more severity in experiencing these symptoms

  2. Mental Health Quality of Life (MHQoL)

    Time frame: 3 to 4 weeks

    Measuring quality of life of individuals. Higher score indicating better quality of life.

  3. Sleep Quality Scale (SQS)

    Time frame: 3 to 4 weeks

    Measuring Sleep Quality of Individuals with higher score denoting more acute sleep problem

Study contacts

Contact information is provided by the study sponsor or research team.

AI SHIN LIM

CONTACT

AI SHIN LIM, PHD

CONTACT

[email protected]

+60162303067

Sponsors and collaborators

Lead sponsor

Monash University Malaysia

Other

Registry information

Official study title

Enhancing the Efficacy of Depression and Low Mood Treatment: A Novel Adjunctive Approach

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
May 30, 2025
Registry last updated
Dec 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.